Concepedia

Lucas Kraft

LK

Statistics

Publications

8

Citations

1.3K

H-Index

8

Active since

2018

Affiliations

AbCellera (Canada)(Current)

National Institutes of Health

Eli Lilly (United States)

National Institute of Allergy and Infectious Diseases

U.S. President's Malaria Initiative

Lucas Kraft is an author at AbCellera (Canada) specializing in medicine, biomarker discovery, and molecular diagnostic techniques.

Top concepts

Publications per year

2018–2023

8

Publications

8

The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates

Bryan E. Jones, Patricia Brown‐Augsburger, Kizzmekia S. Corbett et al. · Science Translational Medicine · 2021 · 484 citations · Full text

LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants

Kathryn Westendorf, Stefanie Žentelis, Lingshu Wang et al. · Cell Reports · 2022 · 452 citations · Full text

LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection

Bryan E. Jones, Patricia Brown‐Augsburger, Kizzmekia S. Corbett et al. · 2020 · 173 citations · Full text

The Molecular Basis for Apolipoprotein E4 as the Major Risk Factor for Late-Onset Alzheimer's Disease

Ana‐Caroline Raulin, Lucas Kraft, Youssra K. Al‐Hilaly et al. · Journal of Molecular Biology · 2019 · 55 citations · Full text

Highly potent, naturally acquired human monoclonal antibodies against Pfs48/45 block Plasmodium falciparum transmission to mosquitoes

Amanda Fabra-García, Sophia Hailemariam, Roos M. de Jong et al. · Immunity · 2023 · 37 citations · Full text

1–5 of 8